Broker Regulation

A recent hearing at the U.S. House of Representative Health Subcommittee of the Energy and Commerce Committee heard testimony from shareholders and policy experts on costs and price transparency.

In part four, we will attempt to explain the actual process plan sponsors and their partners must follow in order to comply with reporting regulations

In part three of this series, we'll look at some obstacles employers and plan sponsors have encountered so far, as well as potential solutions.

In part two in this series, we focus on understanding non-quantitative treatment limitations.

Despite bottlenecks caused by higher than expected dispute resolution claims, the federal No Surprises Act appears to be living up to its name, according to a new survey by AHIP and Blue Cross Blue Shield Association.

These unexpected bills might discourage people from seeking preventive screenings that could be lifesaving, which is why the ACA deemed them "essential health benefits" that should be free.